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Introduction
Thirty years ago liver pathology defined apoptosis as a novel mode of cell death. Recently, experimental models ofliver injury have been made available for examining the signaling molecules and receptors of apoptotic mechanisms as well as their pathological relevance. Experimental evidence suggests the involvement of apoptosis not only in various inflammatory liver disorders, but also in conditions of poisoning with xenobiotic hepatotoxins. The presence of several differentially regulated apoptosismediating receptors and their ligands on hepatocytes may explain the liver's susceptibility to autoimmune reactions, toxins, and viruses causing chronic liver disease, as well as the differential sensitivity of this system in various metabolic and pathologic conditions.
Tumor necrosis factor (TNF) and its receptors (TNF-R), as well as CD95L and its receptor (CD95), are well-known cytokine/cytokine receptor systems relevant to hepatic disease and to apoptosis. Neutralization of endogenously released TNF prevents hepatocyte apoptosis associated with inflammatory liver damage. Direct injection of TNF in sensitized mice results in large scale hepatocyte apoptosis which is exclusively and selectively mediated by the 55-kDa TNF-R. Fulminant apoptotic liver damage is also triggered upon stimulation of CD95. Possible triggering cells include hepatocytes that express CD95L under pathological conditions. Despite the lack of interaction between TNF-R and CD95 on the receptor level, their signal transduction inside the cell seems to involve common proteolytic steps since inhibition of proteases of the caspase family blocks hepatocyte death, liver damage, or lethality in mice signaled by either receptor.
2
Apoptosis vs Necrosis: Definitions and Delimitations
Despite early pioneering studies of pathologists and developmental biologists on programmed cell death in regressing organs and during development, up until the late 1960s cell death had been mostly regarded as a passive and barely regulated event that follows excessive disturbances of cellular homeostasis (see review in Majno and Joris 1995) . Up to that time mechanisms of cell death had been exclusively studied in tissues of multicellular organisms and the events following cell death on the tissue level were termed necrosis. Nowadays, cell death has become an important topic in biochemistry, cell biology, immunology, and molecular biology. In these fields the word necrosis is often used to describe a type of cell demise characterized by edema, swelling, and dysfunction of intracellular organelles, with rupture of the cell membrane and without precedent packaging and ordered fragmentation of the chromatin (for the purposes of this chapter we follow this definition). Since, strictly speaking, the term necrosis refers to post-mortem events in tissues, alternative terms such as oncosis or lytic cell death have been suggested for the description of the above mode of cell demise (Majno and Joris 1995) . Although historically more correct these terms are generally less common.
A different form of cell death with a distinct morphology was first described more than 100 years ago (Flemming 1885; Councilman 1890; Nissen 1886; Pfitzner 1886) . This form of cell death was finally classified as a morphological entity of its own (Table 1 ) with distinct conceptual implications by Kerr, Wyllie, and Currie, and eventually named apoptosis (Kerr et al. 1972) . Its defining features include: shrinkage of the cell, detachment from neighboring cells, preservation of the morphological structure of intracellular organelles, packaging and specific fragmentation of the chromatin, and specific cell membrane alterations indicating the readiness to be phagocytosed. Apoptosis is an inconspicuous type of cell death, allowing rapid removal of the dying cell to prevent tissue damage and inflammation that would otherwise be caused by spilt cell contents (Graper 1914; Savill et al. 1993 ). In addition, apoptosis favors rapid reorganization of the tissue to the original structure, and avoids leakiness of epithelia such as that formed by gut brush border cells. Accordingly, patients may recover from massive, probably apoptotic, hepatocyte loss during fulminant viral hepatitis without scarring (Karvountzis et al. 1974) . In cell cultures exposed to apoptotic stimuli or in pathological situations associated with an extremely high rate of synchronized apoptosis, cells cannot be taken up by phagocytosis and eventually lyse. This process of secondary lysis of originally apoptotic cells is often confusingly called secondary necrosis or apoptotic necrosis. However, this post-mortem process does not seem to be related to necrotic/lytic/oncotic cell demise (which describes the transition ofliving to dead cells).
In parallel to the pathological characterization of apoptosis, developmental biologists discovered a form of "natural" cell death, occurring (Gliicksmann 1951; Saunders 1966; Lockshin and Beaulaton 1974) . Certain cells seemed to be destined (or "programmed") to die at a given stage of development at a given location. In fact, this process of creation of cells that would be eliminated according to a predetermined scheme had already been outlined in 1858 by Virchow in his lecture on atherosclerosis: "Thus, we have here an active process which really produces new tissue, but then hurries on to destruction in consequence of its own development" (Virchow 1858) . It is now clear that most of this so-called programmed developmental cell death is characterized by apoptotic morphology. The terms apoptosis and programmed cell death are therefore currently used as synonyms, although forms of programmed cell death (especially in multinucleated muscle cells) without apoptotic morphology may exist (Schwartz et al.1993; Lockshin and WiIliams 1965) . Notably, it is now evident that there is no absolute requirement of gene induction for programmed cell death or apoptosis to occur. Transcription may be required in many instances in the signaling phase of apoptosis to create a metabolic situation in the cell that would cause a constitutively present core program to be executed (Weil et al. 1996) . This core program may be conceived as the series of partially self-regulatory steps, beyond the signaling phase, that can lead to cell demise. Since the proper execution of these steps commonly results in apoptotic morphology, the term apoptosis has gained a conceptual aspect in addition to its original strictly morphological definition. Recent observations suggest that apoptosis and necrosis present only the two extremes of a continuum of different modes of cell death. It has been experimentally shown that the same stimulus may either induce apoptosis or necrosis, depending on the metabolic situation or the intensity of the insult Nicotera and Leist 1997) . This may be explained by some characteristics of the internal death program: this program does not seem to be strictly linear and sequential, but rather it involves various partially independent branches responsible for the different characteristic features of apoptotic cells (e.g., membrane changes and nuclear changes). The cell will die by pure apoptosis if this program can be run and terminated properly and undisturbed. In contrast, necrosis or intermediate forms are observed if the insult is so intense that only parts of the program can be executed before unspecific events (e.g., failure of ion pumps) lead to membrane rupture. Thus, many intermediate or even completely different morphological (Leist and Wende11996) variants of cell death may exist. In ·experimental studies on liver cell death, a continuum of different modes of cell demise is often observed (Bohlinger et al. 1995; Leist et al. 1996a; Oberhammer et al. 1996; Zeid et al. 1997; Fukuda et al. 1993; Ledda-Columbano et al. 1991; Columbano 1995) . This may be explained by the recruitment of different execution mechanisms in cells exposed to different concentrations of toxins. An alternative explanation has been derived from studies of lymphocyte and neuronal death . The metabolic situation of the cell, in particular the ATP content, may determine the shape and mode of cell demise. For example, when ATP levels were experimentally reduced, typically apoptotic stimuli would result in necrosis (Leist et al. 1997b ).
3
Evidence for Apoptosis in the Liver
Studies on the regressing or pathological liver and on isolated hepatocytes have initially contributed largely to the identification and characterization both of apoptosis and necrosis (Svoboda et al. 1962; Klion and Schaffner 1966; Levy et al. 1968; Kehrer et al. 1990; Orrenius et al. 1989; Kerr 1971 ). However, due to its inconspicuous characteristics the widespread occurrence and relevance of apoptosis for human pathology has been generally appreciated only recently (Que and Gores 1996; Schulte-Hermann et al. 1995) , in contrast to the early recognition of ischemic or necrotic cell death.
3.1
Historical Aspects
Before the term apoptosis was coined (Kerr et al.I972) , the morphological appearance of this mode of cell death in the liver had been known as shrinkage necrosis, Councilman bodies, chromatolysis, acidophilic bodies, or eosinophilic single-cell necrosis, and apoptotic shrinkage of the chromatin was described as pyknosis (Biava and Mukhlova-MontieI1965; Miyai et al. 1962; Moppert et al. 1967; Kerr 1971; Klion and Schaffner 1966; Svoboda et al. 1962; Child and Ruiz 1968) . The earliest descriptions of hepatic apoptosis date back to 1890 with the characterization of histopathology due to yellow fever (Councilman 1890) . Strong interest in hepatic apoptosis developed in the 1960s and the state of the art at that time is compiled in the milestone review by Kerr et al. (1972) . First evidence of intracellular mechanisms characteristic of apoptosis was found in 1970, when Williams described oligonucIeosomal DNA fragmentation in embryonic liver (Williamson 1970) . Despite the appearance of visionary and instructive reviews (Kerr et al. 1972; Wyllie et al. 1980; Searle et al. 1982 Searle et al. , 1987 , the field of apoptosis research hardly moved until the late 1980s, when new methodological approaches finally led to the explosive development seen today.
Inflammation and Hepatic Apoptosis
Apoptosis is a mode of cell death that does not generally favor ensuing inflammation. Accordingly, large numbers of hepatocytes may die by apoptosis without significant enzyme release or inflammation (Hully et al. 1994) . On the other hand, inflammatory mediators often induce hepatocyte apoptosis. In the liver apoptosis and necrosis often occur simultaneously, especially with high intensity insults killing more than 20% of all hepatocytes within hours. Accordingly, apoptotic hepatocytes can be found simultaneously with typical signs of inflammation or hemorrhage.
The prototype of a general inflammatory stimulus is lipopolysaccharide (LPS). This substance has been demonstrated to induce murine hepatocyte apoptosis with concomitant necrosis upon injection of sublethal doses into mice (Levy et al. 1968) . Upon injection of lethal doses, liver damage was predominantly necrotic (Bohlinger et al. 1996) . In addition to LPS, hepatic inflammation may also be induced by injection of D-galactosamine (GaiN). This prototype liver-specific toxin acts by sensitizing the liver towards the effects of endogenous or exogenously applied LPS (Galanos et al. 1979 ; review in Leist et al. 1995a ) and has been shown to induce hepatocyte destruction and apoptosis (Reutter et al. , 1970 Keppler et al. 1968) .
In inflammatory conditions not directly induced by experimental inflammogens there is also evidence of hepatocyte apoptosis: Apoptosis is found during chronic active hepatitis (Kerr et al. 1979; Searle et al. 1982; Hiramatsu et al. 1994 ) and liver allograft rejection (Battersby et al. 1974; Searle and Balderson 1996; Krams et al. 1995; Searle et al. 1982) . In addition, TNF is induced during acute hepatitis (Torre et al. 1994; Ding-feng et al. 1993 ) and type-2 auto immune hepatitis is linked to CD95 mutation (Pensati et al. 1997) . TNF is a powerful inflammogen and has been shown to be a potent inducer of hepatocyte apoptosis in sensitized and non-sensitized mice Leist et al. 1994 ).
3.3
Viral Disease and Apoptosis
There is ample evidence of hepatocyte apoptosis in mouse and man during viral infection (Hiramatsu et al. 1994; Klion and Schaffner 1966; Svoboda et al.1962; Child and Ruiz 1968; Kerr et al.1979; Searle et al.1982) . Additional evidence for induction of liver damage possibly by hepatocyte apoptosis comes from the findings that viral infection strongly sensitizes the liver towards LPS toxicity (Gut et al. 1984; Mori et al. 1981) , and that under defined experimental conditions injection of viral antigens can cause fulminant liver failure (Mori et al. 1981) . Viral infection may result in hepatocyte apoptosis by three conceptionally different mechanisms: (1) Viruses may directly induce apoptosis of cells; (2) hepatocytes presenting viral pep tides may be attacked by cytotoxic lymphocytes that kill their target cell by apoptosis (Kondo et al. 1997) . Accordingly, lymphocytes are found in close association with apoptotic hepatocytes (Bathal et al. 1982; Galle et al. 1995) ; and (3) upon viral infection hepatocytes may become sensitive towards certain apoptosis-inducing cytokines. This concept is based on the following lines of evidence: Firstly, viruses may elicit the production and upregulation of proapoptotic cytokines and their receptors even within hepatocytes (Gonzalez-Amaro et al. 1994; Hiramatsu et al. 1994; Galle et al. 1995) ; secondly, viral infection generally sensitizes cells towards TNF toxicity or TNF-induced apoptosis (Ohno et al.1993; review in Wong et al.1992; Rubin 1992) . Accordingly, TNF is frequently virustatic. The sensitization of cells may be explained by the transcriptional inhibition of cell-specific RNA by viruses (Huang and Wagner 1965) . Under the metabolic condition of transcriptional block hepatocytes are sensitized more than 10 ODD-fold towards TNF-induced apoptosis (Leist et al. 1994 ). In particular, it has been shown that expression of hepatitis B virus (HBV) or HBx protein sensitized cells dose-dependently towards the induction of apoptosis by TNF (Guilhot et al. 1996; Su and Schneider 1997) and expression of HBV protein in transgenic mice sensitized hepatocytes towards TNF-and interferon (IFN)-"{-induced apoptosis and liver damage (Gilles et a1.l992) .
Control of viral infection by apoptosis as opposed to necrosis would provide a considerable advantage to the body. Viral particles would not be Ray et aJ. (1993 Ray et aJ. ( , 1996 ; Blazka et aJ. (1995 Blazka et aJ. ( , 1996 released from dying cells, but rather be digested., after phagocytosis of the membrane-enclosed apoptotic bodies. In addition, viral DNA would be destroyed by the process of oligonucleosomal DNA-fragmentation, that is typically found in hepatocytes killed by TNF or CD95 (Leist et al. 1994 (Leist et al. , 1996a .
Apoptosis Induced by Toxins and Organ Size Regression
It was recognized (Kerr et al.1972) very early that apoptosis is not only the physiological mode of cell death in tissue turnover and development, but it may also be induced by stressful stimuli, toxins, unfavorable environmental conditions, and organ size regression (Ledda- Columbano et al. 1996; Columbano et al.1985; Kerr 1971; Bursch et al.1992; Grasl Kraupp et al. 1994) . Accordingly, a large number of toxins produce hepatocyte apoptosis (Table 2) , often associated with concomitant necrosis. The significance of apoptosis has been little appreciated by many toxicologists in the past. However, in this field the distinction between apoptosis and necrosis may have major practical implications for the interpretation of tissue damage, of the mechanisms leading to cell death, and for the design of preventive therapies.
4
Hepatic Apoptosis Elicited by Cytokine Signaling
Transforming Growth Factor-~
Transforming growth factor (TGF)-~ is involved in many inflammatory processes. However, it differs from classical proinflammatory cytokines since it may also have strong anti-inflammatory (Randow et al. 1995) , cytoprotective (Prehn et al. 1994; Merrill and Zimmerman 1991) , and growth regulatory functions (Bedossa et al. 1995) . In the liver it acts as a negative regulator of hepatocyte growth ) and mediates collagen deposition by Ito cells and fibrosis (Weiner et al. 1990 ). TGF-~ was identified as the first defined mediator eliciting hepatocyte apoptosis (Oberhammer et al. 1991 (Oberhammer et al. -1993a . It seems to be involved in the normal growth regulation of the liver rather than in inflammatory or infectious hepatocyte apoptosis. In fact, TGF-~-induced hepatocyte apoptosis is counteracted by the inflammogen LPS (Martin-Sanz et al. 1996) possibly due to the induction of protective growth factors (Fabregat et al. 1996) . Overexpression ofTGF-~ in transgenic mice leads to multiple tissue lesions, including hepatocyte apoptosis (Sanderson et al. 1995) . The acute hepatocyte toxicity of TGF-~ (~16 h) is relatively low (Oberhammer et al. ,1996 compared to that mediated by TNF or CD95L. However, the mechanism of apoptosis induction by the three cytokines may be similar as far as the activation of caspase-3-related proteases is concerned (Kiinstle et al. 1997; Rodriguez et aL 1996b; Rouquet et aL 1996b; Inayat-Hussain et al. 1997 ). The effects ofTGF-~ after prolonged exposure seem to depend on the metabolic situation of the liver, e.g., TGF-~-induced apoptosis is greatly enhanced in vivo and in vitro by tumor promoters, cyproterone acetate treatment, or conditions of liver size regression (Oberhammer and Qin 1995; Oberhammer et al. 1993a Oberhammer et al. , 1996 . A specific characteristic of TGF-~ is the arrest of apoptotic DNA fragmentation at the level of 50-kbp fragments in rat liver (Oberhammer et al. 1993b) . This is an important example showing that oligonucleosomal DNA fragmentation is not generally required for the apoptotic process. In various hepatoma cell lines TGF-13 induces oligonucleosomal DNA fragmentation (Lin and Chou 1992) , and the related protein activin induces murine hepatic apoptosis associated with oligonucleosomal DNA fragmentation (Hully et al. 1994 ).
Tumor Necrosis Factor
TNFs are cytokines produced mainly by macrophages and T-cells, but under certain metabolic conditions also by many other cell types. Soluble or membrane-bound (Ware et al. 1992 ) TNF-~ (also known as lymphotoxin-a) acts on either TNF receptors (Stauber and Aggarwall989) or, in conjunction with lymphotoxin-~, on a specific lymphotoxin receptor (Crowe et al. 1994; Browning et al. 1993) . TNF-a is initially expressed as a 26-kDa membrane protein. Alternatively, the extracellular 17 -kDa part is released by a metalloproteinase- (Mohler et al. 1994) into the circulation and acts as a trimer on TNF receptors. Both the membrane-bound form and the soluble form have been found to be involved in toxic and inflammatory processes. TNF-a (TNF) is an extremely pleiotropic mediator inducing hepatic acute phase response, hepatic regeneration and growth, stimulation of immune cells, upregulation of adhesion molecules, shock-like conditions, lipolysis, cachexia, tissue destruction, and apoptotic or necrotic cell death in various cell types (Beutler 1992; Aggarwal and Vilcek 1992) . Its cellular effects are mediated by two receptors, i.e., the 55-kDa TNF-RI and the 75-kDa TNF-RIl (Lewis et al. 1991; Tartaglia and Goeddel 1992) . Its signal transduction involves trimerization and consequent binding of intracellular proteins Wallach et al. 1996; Wallach 1997; Darnay and Aggarwal1997) to the cytoplasmic tail of the receptor. The coupling of TNF-RI by various adaptor proteins to distinct downstream signaling pathways has been characterized recently: One pathway ends with the activation of caspases, a second involves the generation of ceramide by neutral sphingomyelinase, a third involves Jun NH2-terminal kinase (JNK) activation, and a further one leads to the activation of the apoptosis-preventing transcription factor nuclear factor (NF)-lCB (Z.G. Adam-Klages et al. 1996) . The most relevant pathway for the initiation of cell death is the activation of caspases with the cleavage of caspase-8 (FLICE) and caspase-lO possibly constituting the first steps in a protease cascade (Boldin et al.1996; Muzio et al. 1996) . This pathway seems to be autoinhibited by the presence of dominant negative variants of caspases in the cell (Wallach 1997; Irmler et al. 1997) , that resemble the viral FLICE-inhibitory proteins (FLIPs) ). In addition, mitochondrial alterations and signals are involved in the toxic effects of TNF in various cell types (Stadler et al.1992; Higuchi et al. 1997; Lancaster et al. 1989; Pastorino et al. 1996) . It is likely that the balance of all these pathways determines the cellular fate.
Studies in Hepatocyte Cultures
The study of TNF-induced apoptosis in isolated hepatocytes has been complicated by the fact that under standard short-term culture conditions, TNF alone induces no or only very a low percentage of hepatocyte death (Guilhot et al.1996; Leist et al.1994 Leist et al. , 1995b Stadler et al.1992; Shinagawa et aL 1991) . Cell death was only observed if TNF was present in excessively high concentrations in combination with IFN-y Billings 1992, 1993) . Under very specialized culture conditions direct hepatocyte apoptosis by TNF is observed (Bour et al. 1996; Ohno and Maier 1995) . This difficulty in studying TNF toxicity in hepatocyte cultures is due to the fact that TNF transmits simultaneously possibly cytotoxic signals, and induces various cytoprotective mechanisms, such as the activation of NF-KB (Z.G. Beutler 1992; Aggarwal and Vilcek 1992) . When these effects are eliminated by blocking transcription, hepatocytes become extremely sensitive to TNF (Leist et al. 1994) . Under these conditions ~800/0 of all cells in culture were killed within 16 h as evidenced by enzyme leakage and loss of the ability to reduce tetrazolium salts. The typical features of cell death were chromatin condensation, budding of the cells, formation of crescent-shaped chromatin lumps and break-up of the chromatin in several apoptotic bodies. These structural changes occurred within hepatocytes which maintained their membrane integrity. In parallel to the structural changes and well before membrane lysis, the DNA fragments and a typical oligonucleosomal pattern of cleavage is observed. All these observations are characteristic of apoptotic cell death. Similar results, i.e., TNF-induced apoptotic cell death under the condition of transcriptional sensitization by actinomycin D (ActD) (Fig. 1) , GaIN, or (lamanitin, were obtained in cultures of HepG2 human hepatoma cells (Leist et al. 1994 (Leist et al. , 1997a . Examination of the signal transduction showed (HepG2) were incubated in the presence of 400 nM actinomycin D plus 1.6 ng/ml recombinant hUI)1an TNF {rhTNF)-a:. MTT-dye reduction (parameter of mitochondrial function), lactate dehydrogenase (LDH) release (parameter for cell membrane rupture), and DNA fragmentation (parameter associated with typically apoptotic nuclear changes) were determined over a time period of 24 h. As is characteristic of apoptotic cell death, DNA fragmentation always preceded the other death parameters. Similar findings have been obtained in primary hepatocyte cultures and murine livers that neither reactive oxygen species (ROS) nor NO, nor any of the various other well-known classical second messengers played a significant role as mediator of apoptotic death (Leist et al. 1994 ).
In Vivo Studies in Mice
TNF has been shown to be hepatotoxic in man and mice (Jones and Selby 1989; Talmadge et al. 1987) . Mice can be dramatically sensitized (up to 10 ODD-fold) by viral or bacterial infection or chemicals such as GalN. The amino sugar GaIN is metabolized by enzymes of galactose metabolism that are only present in hepatocytes. High concentrations of GalN cause a selective depletion of uridine nucleotides in hepatocytes (Decker and Keppler1974). Therefore, they cause a selective transcriptional inhibition in rat or murine ) liver. The mechanism of sensitization towards TNF by this substance is due to the selective facilitation of hepatocyte apoptosis caused by such a transcriptional block (Leist et al. 1994 . Accordingly, selective hepatocyte apoptosis in mice is also observed when GalN is substituted by the general and non-organ-specific transcriptional inhibitors ActD or a-amanitin (Leist et al. 1994 (Leist et al. , 1997a . Hepatocyte apoptosis in vivo develops analogously to that observed in vitro. Condensation, margination, and fragmentation of the chromatin, associated with oligonucleosomal DNA fragmentation precedes the loss of intracellular enzymes or a drop of total glutathione levels as parameters for membrane lysis or oxidative stress, respectively (Leist et al. 1994 . Histological examination of the late phases of TNF-induced liver damage in mice sensitized either by GaIN or ActD showed widespread necrosis, inflammation, and hemorrhage. Thus, there is a sequence of events characterized by initially pure hepatocyte apoptosis that is followed by the simultaneous occurrence of apoptosis and necrosis as the liver damage proceeds to virtually complete destruction of the organ. Similar events are observed if livers are not sensitized by transcriptional inhibitors, but by preceding infection with Propionibacterium. acnes (Tsuji et al. 1997 ). Due to the complexity of the in vivo approach, it is difficult to decide at this point: (1) whether the occurrence of necrosis is due to secondary actions of TNF, possibly involving other cell types (Sauer et al. 1996; Hewett et al. 1993) , (2) whether this is due to an inherent, but direct, necrosiS-inducing activity of TNF, or (3) whether this is due to an incompletely terminated apoptotic program in an overstressed or energy-de-pleted tissue. There is some evidence for each of these possibilities. The last possibility is backed by findings ) that a variety of insults induce apoptosis at low intensities and cause necrosis if the intensity or duration of stress is increased (Dypbukt et al. 1994; Ankarcrona et al. 1995; Bonfoco et al. 1995; Oberhammer et al. 1996; Hartley et al.1994; Lennon et al. 1991; Jensen et al.1992; Corcoran and Ray 1992; Zeid et al. 1997; Fukuda et al. 1993; Ledda-Columbano et al. 1991) . In addition, we found that typically apoptotic stimuli cause necrosis of T cells if their ATP levels are reduced (Leist et al. 1997b) .
The large scale induction of hepatocyte apoptosis in vivo and in vitro suggests that a very effective endogenous death program is present in hepatocytes. This can be very easily triggered under certain metabolic conditions whereas it is efficiently repressed in others. When activated appropriately such a program may provide means to control viral infection and tumor growth in the organ that is most heavily exposed to toxins. If activated inappropriately, it may cause rapid destruction of the organ.
LPS-Induced Endogenous Production ofTNF
In the studies described above, the actions of exogenously applied TNF were examined. Similar results were obtained in pathological model situations of endogenous TNF release. The liver harbors the largest pool of macrophages in the body and thus it is a potent TNF-producing organ (Leist et al. 1996b) . Kupffer cells within the liver may produce TNF after direct stimulation, e.g., with LPS or after interaction with activated lymphocytes in a more complicated immunological setting . Accordingly, LPS injection into GaIN-sensitized mice causes TNF release (Wendel 1990; Jilg et al. 1996) and the typical sequence of selective hepatocyte apoptosis followed by widespread necrosis and enzyme release from the liver . Passive immunization of mice against TNF prevented apoptosis ( Leist et al. 1995b) , as well as transaminase release as a late sign of liver damage Tiegs et al. 1990 ). When doses of LPS lOOO-fold higher than those given to sensitized animals were injected into non-sensitized mice the pathological findings were different (Bohlinger et al. 1996) . Although a strictly TNF-dependent liver damage associated with DNA fragmentation was still observed, the incidence of hepatocyte apoptosis was very low. Liver cell types other than hepatocytes were affected and organ damage was widespread and far from being selective for the liver. Under such an excessive intensity of insult the selective triggering of an apoptotic program may be overridden by many other processes (Gutierrez-Ramos and Bluethmann 1997), such as complement activation, neutrophil immigration and activation (Sauer et al. 1996) , ROS generation, and many more. In addition, a possibly initiated apoptotic process may not be fully executed until the stage of chromatin condensation due to energy failure .
Induction of Endogenous TNF by Stimuli Other Than LPS
LPS is an excellent model stimulus for the induction of circulating TNF in animals and also in man (Zabel et al. 1989 ). The levels of serum TNF reached in humans exposed to LPS are sufficient to induce liver toxicity (Ouo et al. 1996) . Besides LPS, there is a large variety of other stimuli that induce TNF and cause fulminant apoptotic liver failure in GaIN-treated mice. For example, hepatic apoptosis is also observed in GalN-pretreated mice when T cells are polyclonally activated by stimulation of the T cell receptor with an anti-CD3 antibody or the super antigen Staphylococcus aureus enterotoxin B (Gantner et al.I995a) . Both stimuli strongly increase the serum TNF concentrations of mice, and passive immunization against TNF prevented this rise, as well as apoptosis and other signs of liver damage. Similar forms of liver damage are also induced by malarial antigens (Bate et al. 1989; Jakobsen et al. 1997; Taverne et al.1990 ) or constituents of Gram-positive bacteria (Miethke et al.1992 (Miethke et al. , 1993 Sparwasser et al. 1997 ). Thus, it seems that whenever circulating TNF is induced in GaINsensitized mice, liver apoptosis will be observed .
Some animal models exist in which liver damage is induced by endogenous TNF in the absence of transcriptional inhibitors. In one of them, liver damage associated with hepatocyte apoptosis is induced by the polyclonal T cell stimulator concanavalin A (ConA) . Again the rise of serum TNF, of apoptosis, and other signs of damage were not present in mice immunized against TNF. However, mechanisms of liver damage seem to be different from those observed in GalN/TNF models, including those where primarily T cells are activated. For instance, TNF-a -1-mice are normally sensitive to ConA (Tagawa et al. 1997) , whereas TNF-RI -1-mice are protected (Leist et al. , 1996a . Thus TNF-~ may play an important role in this model, at least when it has to compensate for lacking TNF-o:. In addition, it has been found that inhibition of the processing of the 26-kDa membrane-bound TNF-a to its soluble form protected GalN-sensitized mice from LPS toxicity, but enhanced the liver damage in Con A-treated mice (Solorzano et al. 1997) . Thus ConA hepatitis possibly involves signals of the membrane-bound form of TNF (Kiisters et al. 1997 ) that preferentially activates TNF-RII (Grell et al. 1995) . A further feature of ConA-induced liver damage is the dependence on IFN-y (Tagawa et al. 1997; Kiisters et al. 1996; Watanabe et al. 1996) . IFN-y may exert direct toxicity on hepatocytes (Morita et al. 1995) . However, the more likely role of this cytokine is up regulation of CD95 or perforin-dependent pathways, which may both play some role in ConA-dependent hepatic apoptosis (Watanabe et a1.1996; Tagawa et al. 1997) .
Another situation where TNF-dependent liver apoptosis is observed is in LPS-challenged mice pretreated with P. acnes (previously called Corynebacterium parvum) (Tsuji et a1.1997) . The pretreatment strongly increases production of TNF (Moldawer et al. 1987 ) and of IFN -y (Katschinski et al. 1992) . In this complex model, hepatocyte apoptosis may be dependent on TNF-R and on CD95 since toxicity is considerably reduced in CD95-deficient mice or when the activation of CD95 is inhibited (Tsuji et al. 1997; Kondo et al. 1997 ).
CD95 (fas/APO-l)
CD95 (Nagata and Golstein 1995; Nagata 1997; Stanger 1996) is the nomenclature name for a cell surface receptor structurally homologous to TNF-RI that was initially identified under the names APO-1 (Oehm et al. 1992) and fas (Yonehara et al. 1989) . It shares with TNF-RI a short intracellular domain called the "death domain" (Tartaglia et al. 1993; Itoh and Nagata 1993) . Upon ligand binding and trimerization of the receptor a death-inducing signaling complex (DISC) is formed by association of several molecules to the death domain (Peter et a1.1996) . Following DISC formation a protease cascade involving caspases is triggered Muzio et al. 1996) . The CD95 system seems to be less pleiotropic than the TNF/TNF-R system and cell death mediated by CD95 is generally apoptotic.
Studies in Hepatocyte Cultures
It was shown that injection of an agonistic mono clonal antibody against CD95 (Jo-2) into mice was lethal and associated with fulminant hemorrhagic hepatic failure (Ogasawara et al. 1993) . Histological examination of these livers showed apoptotic hepatocytes. In order to find out whether these effects of Jo-2 were mediated directly or via other cell types and/or mediators, the action of this antibody was examined directly on primary murine hepatocytes (Leist et al. 1996a ). Analogously to the TNF model a typical sequence of apoptotic events was observed with chromatin and DNA changes preceding the loss of membrane integrity and mitochondrial function. Similar results were obtained in primary human hepatocytes (Galle et al. 1995) . Notably, murine hepatocyte apoptosis induced by CD95 stimulation did not require any sensitization of the cells. CD95-induced apoptosis in HepG2 human hepatoma cells, however, required sensitization by ActD or bleomycin (Galle et al. 1995; Kunstle et al. 1997 ). These studies suggest that hepatocytes express a second receptor that can directly trigger programmed cell death.
In Vivo Studies in Mice
RNAse protection assays showed that CD95 is highly expressed in murine livers starting at embryonic stages, whereas RNA for the CD95L was not detectable in untreated mice (French et al. 1996) . There are situations when CD95L can be upregulated in the liver, e.g., after transformation to hepatocellular. carcinoma (Strand et al. 1996) . Upregulation may also occur during infection/inflammation in viral or alcoholic liver disease (Galle et al. 1995) , or possibly near the central vein, a region that is thought to be specialized for elimination of aged hepatocytes and where the apoptotic index is increased compared to other liver regions (Benedetti et al. 1988) . Correspondingly, mice with a CD95 null mutation show liver hyperplasia due to a lack of this death pathway (Adachi et al. 1995) .
CD95 expressed in the liver is functional as an apoptosis-triggering-receptor, since the liver is the major target organ affected by systemic injection of Jo-2 (Ogasawara et al. 1993) . It was shown that apoptotic liver damage also occurred after injection of the soluble CD95 ligand (CD95L) itself (Rensing-Ehl et al. 1995; Tanaka et al. 1997) . The time course of various cell death parameters, and the question of whether the liver could be sensitized to CD95 triggered apoptosis by GalN was also examined. Analogous to the in vitro situation, only a minor sensitizing effect of GaIN towards CD95-mediated liver damage was found, but the sequence of events (chromatin changes, oligonucIeosomal DNA fragmentation, and subsequent enzyme release) was similar to that seen with GalN plus TNF (Leist et al. 1996a) . Strong evidence for endogenously formed CD95L in hepatitis comes from studies with models where IFN -ris strongly induced. For example, liver damage due to P. acnes plus LPS seems to be mediated in part by CD95 (Kondo et al. 1997; Tagawa et al. 1997) and P. acnes infection strongly sensitizes the liver towards soluble CD95L (Tanaka et al. 1997 ). In addition it has been demonstrated that cytotoxic T cells specific for hepatitis B virus antigen killed infected hepatocytes in a CD95-dependent manner (Kondo et al. 1997 ).
Delimitation of the CD95/CD95L System and the TNF-RITNF System
Due to the structural homology of CD95 with TNF-RI and CD95L with TNF and because of the functional redundancy there were early suggestions that these systems would not act independently. This question was examined by using mice or hepatocytes from mice (Fig. 2) that lacked either functional CD95 (lpr) or TNF-RI (tnf-l°) or TNF-RII (tnf-R2°) (Leist et al. 1996a ).
-Hepatocytes from Ipr mice reacted toward TNF just as wild-type (wt) mice, but were insensitive towards CD95 stimulation. Similar results were obtained in vivo: Ipr mice reacted normally towards exogenously injected TNF or after endogenous TNF-induction due to ConA injection, whereas they were insensitive towards CD95 stimulation. -In complementary experiments hepatocytes from tnf-rl° mice were used (Leist et al. , 1996a . They were completely insensitive towards TNF, but normally susceptible to CD95 stimulation. Similar results were obtained in vivo (Leist et al. , 1996a Tsuji et al.I997 ). -In a third line of experiments, the role of TNF-RII was tested. Hepatocytes from tnf-r2° mice were normally sensitive towards CD95 stimulation and exposure to TNF in vivo or in vitro. In other words, TNF-RII does not seem to play a major role in the induction of apoptosis by TNF. alone is further suggested by the fact that human TNF (which binds to the murinoe TNF-RI, but not to the murine TNF-RII) induces murine hepatocyte apoptosis in vivo and in vitro (Leist et o al.1995b) (Fig. 2) .
These studies strongly suggest that two fully independent receptor-ligand systems control hepatocyte apoptosis (Fig. 3) . Additional evidence is provided by the observations that TNF apoptosis is modulated by GaIN or variable ambient oxygen tensions, whereas that induced by CD95 stimulation is not (Leist et al. 1996a) . Furthermore, the inhibition proflle upon immunological, pharmacological, or genetic intervention differs between the two stimuli.
5
Mechanisms and Modulation of Hepatic Apoptosis
Modulation of hepatic apoptosis is desirable in disease control. Conversely, important mechanistic information can be derived from genetic, pharmacological, and immunologic intervention studies in disease models. 
Key Mechanisms of Apoptosis
There is an overwhelming wealth of studies on either hepatocyte necrosis or on non-hepatocyte apoptosis. However, information on specific mechanisms of apoptosis in primary hepatocytes in vitro or in experimental animals in vivo is relatively sparse. Unlike the situation in many leukemicltumor cell lines that mostly die by apoptosis, triggering of cell death in hepatocytes by a variety of stimuli often results in necrosis (Rosser and Gores 1995) . This does not necessarily imply a different "death program" in hepatocytes, since apoptosis and necrosis are neither mechanisms of cell death nor do they allow conclusions on the mechanism having led to cell death. In fact, similar mechanisms seem to operate in hepatocytes as in many other well characterized cell types, although the final outcome may be apoptosis or necrosis.
The most critical event in apoptosis is currently thought to be the release of protein factors such as cytochrome c or apoptosis-inducing factor (AIF) from mitochondria (Krippner et al. 1996; Golstein 1997; Zamzami et al. 1996; Kluck et al. 1997; Susin et al. 1996 Susin et al. , 1997 Yang et al. 1997; X. Liu et al. 1996; Kroemer et al. 1997) . The released factors seem to play a role in the activation of cell death execution mechanisms Chinnaiyan et al. 1997a; Susin et al. 1997 ). Possibly, they form part of a so-called apoptosome complex that joins caspase precursors and bcl-2 related molecules via a linking protein that is called ced-4 in Caenorhabditis elegans and APAF-l in eukaryotic cells (Chinnaiyan et al. 1997b; Hengartner 1997; Zou et al.1997 ). APAF-l or ced-4 may be allosterically regulated by ATP (Chinnaiyan et al. 1997a ). The key process associated with the release of AIF is mitochondrial permeability transition (MPT), i.e., a breakdown of the diffusion barrier normally formed by the inner mitochondrial membrane and a resulting exchange of solutes up to a size of 3-10 kDa (Kroemer 1997a,b) . MPT was in fact observed in livers from GaIN-/LPS-challenged mice ; mitochondria from such livers were able to induce nuclear apoptotic changes , and TNF has been shown to induce MPT in cells (Pastorino et al. 1996) . MPT has also been observed in hepatocyte necrosis (Pastorino et al. 1993; Aguilar et al. 1996; Rosser and Gores 1995; Nieminen et al. 1995; Arora et al. 1997 ) and therefore seems to be independent of a specific mode of cell death. Another event, which has been thought to be a universal feature in apoptosis, is caspase activation. In fact, caspases are activated for example in CD95-triggered livers or primary hepatocytes (Rodriguez et al. 1996b; Leist et al. 1997c ). However, both apoptosis and necrosis induced by CD95 in murine livers are inhibited by caspase inhibitors (Kiinstle et al. 1997) . Moreover, there are also situations of hepatic apoptosis that do not involve caspase activation (Adjei et al. 1996) . Possibly other pro teases can substitute for caspases in the liver;. for example, MPT has been shown to be induced in liver by calpains (Aguilar et al. 1996) .
Although protease activation seems to be a general theme of hepatocyte death, this may apply to both apoptosis and necrosis (Bronk and Gores 1993; Kwo et al.1995; Nicotera et al.1986a,b) .
The complex situation can be explained by the following concept (see Fig. 3 ): (a) Various stimuli may induce the activation of proteases or other disturbances of cellular homeostasis. In the case of TNF or CD95 caspases 8 and 10, for example, would be activated. (b) Depending on the metabolic situation, hepatocytes would compensate the noxious insult, die rapidly by necrosis, or proceed to the next step of the death program. (c) MPT would mark the irreversible step in the sequence leading to cell death. (d) The metabolic situation of the cell and on additional effects of the death-inducing stimulus would then decide on the mode/shape of cell death. In the case of TNF/CD95 caspase-3-related proteases would be activated and usually apoptosis would ensue. In other cases only part of the set of downstream events triggered by MPT would occur. This would prevent the development of apoptotic morphology in the dying cell and thus lead to necrosis. Prevention of caspase-3 activation by ATP depletion in CD95-treated Jurkat cells has been demonstrated to result in necrotic cell demise (Leist et al. 1997b ).
Pharmacological Prevention of Apoptosis
Since the signal transduction of CD95 and TNF-Rl has been identified only over the last few years, earlier intervention strategies could not follow a rational approach at the post-receptor level. Partial prevention of TNFinduced apoptosis in hepatocyte cultures and a reduction of liver damage in vivo was obtained by cyclic adenosine monophosphate (cAMP)-raising substances (Jilg et al. 1996; Gantner et al. 1997; Fladmark et al. 1997) . A selective and potent reduction of TNF-induced apoptosis, but not of that induced by CD95, was obtained with fructose treatment (unpublished data), possibly due to the ATP-depleting action (Zeid et al.1997; Valeri et al. 1997 ) of this sugar. Liver damage due to CD95 activation was prevented by linomide, a substance possibly preventing the intracellular signaling of CD95 via the sphingomyelinase pathway (Redondo et al. 1996) .
The most rational pharmacological approach in the past was based on the assumption that components of the death program may require de novo protein synthesis. ActD-sensitized murine hepatocyte cultures were indeed protected by various inhibitors of protein synthesis from TNF-induced apoptosis. Concentration-dependent protection was observed with cycloheximide, puromycin, ricin, and tunicamycin (Leist et al. 1994; Leist and WendeI1995) , which may suggest a requirement for de novo protein synthesis. However, cycloheximide may also induce apoptosis in whole livers (Ledda-Columbano et al. 1992; Furukawa et al. 1997 ) and alternative mechanisms of action have been suggested to explain cytoprotective effects of cycloheximide. These include upregulation of the anti-apoptotic protein Bcl-2 and an improvement of endogenous antioxidant defense (Ratan et al. 1994) . Protein synthesis inhibitors alone had hardly any sensitizing effect towards TNF in murine hepatocytes. Notably; when human hepatoma cells were used, they could be sensitized towards TNF by cycloheximide or ActD. Protein synthesis inhibitors did not protect from apoptosis elicited by CD95 stimulation, but rather had a sensitizing effect (Ni et al. 1994) .
In 1995, the intracellular pathway leading from TNF-R stimulation to apoptosis was shown in various cell types to involve activation and proteolytic action of caspases (Los et aL 1995; Tewari and Dixit 1995; Enari et al. 1995) . This family of proteases is structurally related to the ced-3 cell death gene products of C. elegans (Kumar and Lavin 1996; Zhivotovsky et al. 1997; Henkart 1996; Patel et al. 1996) . Inhibition of these proteases was tested as a potentially useful pharmacological approach to stop disease processes involving hepatocyte apoptosis (Kiinstle et al. 1997; Rouquet et al. 1996b; Rodriguez et al. 1996b) . The results showed unambiguously that both TNF-and CD95-mediated hepatic apoptosis in mice was completely prevented when caspase activities were blocked. In addition, liver damage could even be stopped after its initiation by curative application of caspase inhibitors. Measurement of caspase activities in hepatocytes suggests a caspase-3-related enzyme as key mediator (Leist et al. 1997c) . In agreement with this, measurement of caspase activities in vivo showed that this enzyme was particularly activated in the liver by CD95 stimulation (Rodriguez et al. 1996b) . Finally, caspase inhibitors were shown not only to delay hepatotoxicity or to shift the toxicity to another organ, but rather, a single dose of inhibitor was sufficient to protect from an otherwise lethal challenge with TNF or aCD95 and to ensure long-term survival (Fig. 4) . Although the inhibitors used are still at an experimental stage, they suggest a novel pharmacological approach to apoptosis-related liver disease.
5.3
Immunological and Genetic Modulation of Apoptosis TNF-induced murine hepatic apoptosis can be inhibited in vivo by immune modulators. For example, it has been shown that injection of the NO donor sodium nitroprusside or interleukin (IL)-1 completely prevented liver damage (Bohlinger et al. 1995; Leist et al. 1995a ). Conversely, inhibition of endogenous NO formation significantly enhanced TNF-dependent liver damage (Bohlinger et al. 1995 (Bohlinger et al. , 1996 , so that NO production seems to represent an endogenous protective mechanism in the liver. In fact, direct protective effects of NO pretreatment against TNF-induced apoptosis have been observed with a liver-specific NO donor (Saavedra et al. 1997) . Under this situation inhibition of apoptosis seems to have been due to upregula-100 .... tion of heat shock protein hsp70 . The protective effect of IL-l in vivo is specific for TNF-induced toxicity since liver damage due to CD95 stimulation was not reduced by this cytokine (Leist et al. 1996a ). In addition to direct effects of NO on hepatotoxicity, NO or IL-l may have indirect in vivo actions, e.g., the synthesis of protective acute phase proteins (Libert et al. 1991 (Libert et al. , 1994 Van Molle et al. 1997) , or the prevention of ischemia-reperfusion (Bohlinger et al. 1996) . Molecules modifying the CD95 apoptosis signal inside the cell have been examined by using transgenic mice. In an elegant approach bcl-2, a gene putatively controlling apoptosis at the mitochondrial level and upstream of caspase-3 activation, was overexpressed selectively in murine livers (Lacronique et al. 1996; Rodriguez et al. 1996a) . Such transgenic mice were resistant to CD95-induced hepatic apoptosis and, in part, lethality. This approach shows that lethality induced by systemic CD95 stimulation in mice is to a large extent due to stimulation of apoptosis in hepatocytes and the subsequent liver failure.
In another approach a non-transforming mutant of simian virus (SV)-40 T antigen was overexpressed in mice. This molecule does not transform cells, but it is able to inactivate the putatively proapoptotic protein p53 (Rouquet et al. 1996a) . Hepatocytes from such mice were protected from CD95-mediated apoptosis, but not from TNF. These findings suggest a variance of the two signal transduction pathways of TNF-RI and CD95, although both have caspase activation in common. The possible involvement of p53 in CD95 killing but not in TNF-triggered apoptosis suggests that hepatic apoptosis may be modulated differentially.
6
Apoptosis in Hepatotoxicology
Hepatotoxins may induce apoptosis (Corcoran et al. 1994; Columbano 1995) in two fundamentally different ways (Fig. 5): (1) In vitro, substances such as valinomycin (Sun et al.I994) ,colchicine (Tsukidate et al.I993) ,bile salts (Zeid et al. 1997 : Botla et al. 1995 : Kwo et al. 1995 Patel et al. 1994; Jones et al. 1997) , and okadaic acid (Boe et al. 1991 ) directly induce cellular alterations that finally lead to apoptosis, pOSSibly via the activation of caspases. (2) In vivo, the same direct mechanisms may operate. Alternatively, toxins may lead to the stimulation ofhepatocytes with proapoptotic cytokines and sensitize them in parallel to the action of such mediators, Particularly the second, indirect mode of action has found little attention and will be briefly reviewed below.
6.1
Mediators Derived From Non-parenchymal Cells and Cytokines in Hepatotoxicology
It seems that in vivo a large fraction of the most typical hepatotoxins alter the intercellular signaling (e.g., induce cytokine release or response) or act in synergy with intercellular signals (Table 2 ). This would imply that the explanation of their toxicity involves detailed intercellular molecular events in addition to their directly damaging effect on membranes or on vital structures within the ultimate target cell. The evidence for the involvement of immune mediators, non-parenchymalliver cells, and macrophage-derived products in toxicity has been compiled by Laskin and Pendino (1995) . There are various studies showing that modulation of macrophage function or neutralization of immune mediators alters xenobiotic-induced toxicity ( Table 2) . One of the most prominent mediators is the proapoptotic cytokine TNF.
Toxin-Induced Apoptosis
Evidence is accumulating to show that many xenobiotics cause apoptosis (Corcoran et al.1994; Columbano 1995) or symptoms of hepatocyte apoptosis in rodents (see Table 2 ). This suggests that apoptosis in the liver is not restricted to physiological situations alone. The frequent co-occurrence of apoptosis and necrosis in the liver may imply that the default mode of demise for hepatocytes is apoptosis, as for many other cell types. However, many intoxications would damage hepatocytes so severely that the apoptotic program would not be continued to the end and cell death would take the shape of necrosis .
TNF as Mediator ofToxin-lnduced Apoptosis
If a single toxin releases TNF and simultaneously sensitizes cells towards the apoptotic actions of this cytokine, then TNF-induced hepatocyte apoptosis should contribute significantly to overall toxicity (see Fig. 5 ).
For some toxins such a scenario has been demonstrated. For example, the toxicity of CC4, the prototype of a directly acting hepatotoxin, is inhibited by scavenging of TNF with recombinant soluble TNF-receptor constructs (Czaja et al. 1995) .
In another study, the role of TNF and hepatocyte apoptosis during the poisoning of mice with a-amanitin or with ActD, respectively, was examined (Leist et al.1997a) . Indeed, the two toxins displayed similar actions on the liver. At low doses they induced hepatocyte apoptosis in vivo and in vitro highly synergistic with TNF. At high doses they induced liver damage alone that was associated with the occurrence of apoptotic hepatocytes and oligonucleosomal DNA fragmentation. This toxicity was inhibited by passive immunization of mice against TNF. Toxicity was also prevented by IL-1 pretreatment, which has been shown to prevent TNF-induced hepatocyte apoptosis (Bohlinger et al. 1996) . The necessity of TNF for hepatotoxicity was further confirmed by the resistance of tnf-rl° mice and the unaltered sensitivity of tnf-r2° mice to a-amanitin. Thus, different lines of evidence suggest that hepatotoxicity of ActD or a-amanitin, a prototype "direct-acting" hepatotoxin, involves the actions of TNF and the induction of apoptosis in hepatocytes. Also, the "direct" hepatotoxic effect of GaIN was reexamined. Selective liver failure caused by this substance in rodents was suggested 30 years ago to represent a model for human viraI hepatitis (Keppler et aI.1968) . In fact, hepatocyte apoptosis (Councilman bodies) was noted to be one of the most conspicuous phenomena of GaiN-induced pathology (Reutter et al. ,1970 Keppler et al. 1968; Medline et aI. 1970) . A series of studies in the 1970s and 1980s showed that the substance exerted a very pronounced toxicity in synergy with endogenous and exogenous immune modulators (Griin and Liehr 1976; Liehr et al. 1978; Mihas et aI. 1990; GaIanos et al. 1979; Czaja et al. 1994 ). Finally, it was shown that GaiN specifically sensitized mice to the lethality of TNF (Lehmann et al. 1987) , which is due to selective liver failure (Tiegs et al. 1989 ) associated with apoptotic hepatocyte death ). In analogy to the studies on ActD and a-amanitin toxicity, it was examined whether endogenous TNF would contribute to the putatively direct hepatotoxic effect of pure GaiN. In fact, inhibition of liver failure and hepatocyte apoptosis by blunting the effects of endogenously formed TNF demonstrates the role ofTNF in GaIN hepatotoxicity (Fig. 6 ) .
• These findings appear to close a historic circle. Transcriptional inhibition by the xenobiotic GalN sensitizes hepatocytes to apoptosis triggered by endogenous TNF. As suggested initially, this may indeed resemble the situation during viral hepatitis. This may not only apply to the morphological appearance, but also to the mechanisms of hepatocyte death. The simple xenobiotic GaIN may model some aspects of viral infection where transcription of the hepatocyte genome is partially blocked by viral protein synthesis and apoptosis is induced in virus-sensitized cells by endogenous TNF (Guilhot et al. 1996; Su and Schneider 1997) . 
